February 21, 2019 09:00 ET | Source: Metatron Inc.
DOVER, DE, Feb. 21, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Metatron (OTC: MRNJ), a mobile and web technology pioneer having developed over 2,000 apps on iTunes and Google Play, is pleased to announce a collaboration with Krave Games LLC which has lead to the release of their first game together, an addicting space themed mobile game app called Holo Ball for the iPhone and iPad.
Krave brings to the table its mobile game development expertise and has access to networks of millions of Instagram and social media followers. The two companies plan to conduct a shared roll out of multiple mobile applications geared towards gaming, entertainment, and lifestyle categories.
With the popular online presence behind Krave games, the reactions to Holo Ball’s release are exceeding expectations and users can’t seem to get enough. Players having been giving raving reviews on the game and are excited to see the next releases from the partnership of Krave and Metatron.
Holo Ball has been released for iOS and is currently available on the iTunes app store. Version 1.1 of the game was released on February 18, 2019 and currently has a 5 star rating. The new free ad-supported game can be downloaded at http://bit.ly/HoloBallFree.
According to Small Biz Daily, the #1 most popular iOS Mobile Applications category is games, and in 2018 games accounted for 76% of the expected 92.1 Billion mobile app revenue. Having grown from 42.5 billion in 2016, it is expected to reach 106.4 billion in 2021, which is a compound growth rate of 20.1%.
With gaming apps continuing to grow in popularity, Krave and Metatron are thrilled to bring the freshest games to the iTunes Store, something that people Krave– “It’s addictingly good.”
Metatron apps:
iTunes: http://bit.ly/MRNJapps
Google Play: http://bit.ly/1O64fX9
Social Media:
Facebook:http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog
KraveGames.com
Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward looking statement. Metatron retained Global Discovery Group Inc. for $30,500 for consulting services, CSC Partners for $1,500, Bas1 for $2501 and the company retained Pacific Equity Alliance LLC by issuing Integrative Business Alliance LLC 100m rule 144 for 1 year consulting services. Metatron does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.